Pathophysiology features of evolving bronchopulmonary dysplasia: insights from a clinical and translational study

Carlotta Boggi, University of Parma, Parma, Emilia-Romagna, Italy; Chiara Catozzi, Chiesi Farmaceutici Spa, Parma, Emilia-Romagna, Italy; Matteo Storti, Chiesi Farmaceutici, Parma, Emilia-Romagna, Italy; Erica Ferrini, Chiesi Farmaceutici S.p.A., Parma, Emilia-Romagna, Italy; Franco Fabio Stellari, Chiesi Farmaceutici S.p.A., Parma, Emilia-Romagna, Italy; Enrica Scalera, CHIESI FARMACEUTICI S.P.A., Parma, Emilia-Romagna, Italy; Aurora Radicati, Chiesi S.p.A, Parma, Emilia-Romagna, Italy; Giorgio Aquila, Chiesi Farmaceutici Spa, Parma, Emilia-Romagna, Italy; Simone De Meo, University of Siena, Formia, Lazio, Italy; Leonardo Novelli, University of Parma, Santo Stefano di Magra, Liguria, Italy; Angelo Modena, Università del Piemonte Orientale, Parma, Italy, Emilia-Romagna, Italy; Xabier Murguia Esteve, Consultant in Biomedical Science (Freelance), Bilbao, Pais Vasco, Spain; Francesca Ricci, Chiesi Farmaceuitci, PARMA, Emilia-Romagna, Italy; Daniele De Luca, Paris Saclay University-APHP, Paris, Ile-de-France, France